Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1803
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease ; volume:112 ; number:3 ; day:24 ; month:4 ; year:2017 ; pages:1-23 ; date:5.2017
Basic research in cardiology ; 112, Heft 3 (24.4.2017), 1-23, 5.2017
- Schlagwort
-
Physiologische Chemie
- Urheber
-
Glerup, Simon
- Beteiligte Personen und Organisationen
-
Schulz, Rainer
Laufs, Ulrich
Schlüter, Klaus-Dieter
SpringerLink (Online service)
- DOI
-
10.1007/s00395-017-0619-0
- URN
-
urn:nbn:de:1111-201705066389
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Glerup, Simon
- Schulz, Rainer
- Laufs, Ulrich
- Schlüter, Klaus-Dieter
- SpringerLink (Online service)
Ähnliche Objekte (12)
PCSK9 inhibitors in the prevention of cardiovascular disease
Physiological insights of recent clinical diagnostic and therapeutic technologies for cardiovascular diseases
PCSK9 : A Multi-Faceted Protein that is Involved in Cardiovascular Biology
PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Gene Therapy Targeting PCSK9
Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Cardiovascular and cardiac therapeutic devices
Therapeutic angiogenesis for cardiovascular disease
PCSK9 inhibitors in the prevention of cardiovascular disease
Physiological insights of recent clinical diagnostic and therapeutic technologies for cardiovascular diseases
PCSK9 : A Multi-Faceted Protein that is Involved in Cardiovascular Biology
PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Gene Therapy Targeting PCSK9
Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Cardiovascular and cardiac therapeutic devices
Therapeutic angiogenesis for cardiovascular disease
PCSK9 inhibitors in the prevention of cardiovascular disease
Physiological insights of recent clinical diagnostic and therapeutic technologies for cardiovascular diseases
PCSK9 : A Multi-Faceted Protein that is Involved in Cardiovascular Biology
PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Gene Therapy Targeting PCSK9
Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Cardiovascular and cardiac therapeutic devices